{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:33:29Z","timestamp":1767598409260,"version":"3.40.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.biologicals.2013.11.003","type":"journal-article","created":{"date-parts":[[2013,12,8]],"date-time":"2013-12-08T04:00:24Z","timestamp":1386475224000},"page":"42-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A sensitive in\u00a0vitro assay for the detection of residual viable rabies virus in inactivated rabies vaccines"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3805-4165","authenticated-orcid":false,"given":"Mutsuyo","family":"Takayama-Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Nakamichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satsuki","family":"Kakiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Kurane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Kweng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2013.11.003_bib1","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.biologicals.2013.11.003_bib2","first-page":"177","article-title":"An outbreak of post-vaccinal rabies (rage de laboratoire) in Fortaleza, Brazil, in 1960. Residual fixed virus as the etiological agent","volume":"33","author":"Par\u00e1","year":"1965","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.biologicals.2013.11.003_bib3","first-page":"287","article-title":"Notice to Readers: manufacturer's recall of human rabies vaccine","volume":"53","author":"CDC","year":"2004","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.biologicals.2013.11.003_bib4","series-title":"Monograph 0216","first-page":"699","article-title":"Rabies vaccine for human use prepared in cell cultures","author":"European Pharmacopoeia","year":"2008"},{"key":"10.1016\/j.biologicals.2013.11.003_bib5","series-title":"Rabies vaccine","first-page":"1887","author":"U.S. Pharmacopoeia","year":"2012"},{"key":"10.1016\/j.biologicals.2013.11.003_bib6","series-title":"Monograph 0451","article-title":"Rabies veterinary vaccine, inactivated","author":"British Pharmacopoeia","year":"2012"},{"key":"10.1016\/j.biologicals.2013.11.003_bib7","series-title":"Freeze-dried inactivated tissue culture rabies vaccine: in official monographs","first-page":"1333","author":"The Japanese Pharmacopoeia","year":"2011"},{"key":"10.1016\/j.biologicals.2013.11.003_bib8","series-title":"Minimum requirements for biological products","first-page":"40","article-title":"Freeze-dried inactivated tissue culture rabies vaccine","author":"National Institute of Infectious Diseases","year":"2006"},{"key":"10.1016\/j.biologicals.2013.11.003_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.provac.2011.10.025","article-title":"Veterinary vaccine post-licensing safety testing: overview of current regulatory requirements and accepted alternatives","volume":"5","author":"Gifford","year":"2011","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.biologicals.2013.11.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.provac.2011.10.001","article-title":"The international workshop on alternative methods to reduce, refine, and replace the use of animals in vaccine potency and safety testing: introduction and summary","volume":"5","author":"Stokes","year":"2011","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.biologicals.2013.11.003_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.provac.2011.10.007","article-title":"Alternative methods and strategies to reduce, refine, and replace animal use for veterinary vaccine post-licensing safety testing: state of the science and future directions","volume":"5","author":"Kulpa-Eddy","year":"2011","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.biologicals.2013.11.003_bib12","first-page":"83","article-title":"Annex 2 Recommendations for inactivated rabies vaccine for human use produced in cell substrates and embryonated eggs","volume":"vol. 941","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.biologicals.2013.11.003_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/026119290303100409","article-title":"Three Rs approaches in the quality control of inactivated rabies vaccines","volume":"31","author":"Bruckner","year":"2003","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.biologicals.2013.11.003_bib14","first-page":"46","article-title":"How to prove complete virus inactivation in rabies vaccines. A comparison of an in\u00a0vivo to an in\u00a0vitro method","volume":"15","author":"Blum","year":"1998","journal-title":"Altex"},{"key":"10.1016\/j.biologicals.2013.11.003_bib15","series-title":"Virus vaccines in Asian countries","first-page":"83","article-title":"Production and quality control of rabies vaccine","author":"Yamada","year":"1986"},{"key":"10.1016\/j.biologicals.2013.11.003_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0042-6822(65)90160-1","article-title":"Growth characteristics of rabies virus in primary chick embryo cells","volume":"27","author":"Kondo","year":"1965","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2013.11.003_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4269\/ajtmh.1991.44.131","article-title":"Studies on Japanese-produced chick embryo cell culture rabies vaccines","volume":"44","author":"Arai","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2013.11.003_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/jimmunol.64.3.185","article-title":"Studies on chick-embryo adapted rabies virus. II. Pathogenicity for dogs and use of egg-adapted strains for vaccination purposes","volume":"64","author":"Koprowski","year":"1950","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2013.11.003_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0166-0934(02)00249-5","article-title":"An improved method\u00a0for recovering rabies virus from cloned cDNA","volume":"107","author":"Inoue","year":"2003","journal-title":"J\u00a0Virol Methods"},{"key":"10.1016\/j.biologicals.2013.11.003_bib20","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ijid.2010.07.004","article-title":"Utility of human embryonic kidney cell line HEK-293 for rapid isolation of fixed and street rabies viruses: comparison with Neuro-2a and BHK-21 cell lines","volume":"14","author":"Madhusudana","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.biologicals.2013.11.003_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1744-7348.1935.tb07713.x","article-title":"The calculation of the dosage-mortality curve","volume":"22","author":"Bliss","year":"1935","journal-title":"Ann Appl Biol"},{"key":"10.1016\/j.biologicals.2013.11.003_bib22","first-page":"192","article-title":"The determination of the dosage-mortality curve from small numbers, Quart","volume":"11","author":"Bliss","year":"1938","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.biologicals.2013.11.003_bib23","unstructured":"Validation of analytical procedures: methodology. Implemented in October 1999. Available at: http:\/\/www.vichsec.org\/pdf\/gl02_st7.pdf."},{"key":"10.1016\/j.biologicals.2013.11.003_bib24","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1128\/AEM.22.4.600-603.1971","article-title":"Sensitive procedure for detecting residual viable virus in inactivated rabies vaccine","volume":"22","author":"Mitchell","year":"1971","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.biologicals.2013.11.003_bib25","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1016\/j.vaccine.2007.07.011","article-title":"A\u00a0sensitive cell-based assay for the detection of residual infectious West Nile virus","volume":"25","author":"Koldijk","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.11.003_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.biologicals.2005.05.003","article-title":"Validation of the inactivant binary ethylenimine for inactivating rabies virus for veterinary rabies vaccine production","volume":"33","author":"Mondal","year":"2005","journal-title":"Biologicals"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613001358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613001358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T20:47:47Z","timestamp":1688849267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105613001358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1045105613001358"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2013.11.003","relation":{},"ISSN":["1045-1056"],"issn-type":[{"type":"print","value":"1045-1056"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A sensitive in\u00a0vitro assay for the detection of residual viable rabies virus in inactivated rabies vaccines","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2013.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}